This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEB9606Q_M.jpg
The IPO includes an Offer for Sale (OFS) of 2.4 crore equity shares by promoters Akshay Bansarilal Arora and Shiven Akshay Arora. Allocations have been reserved for Qualified Institutional Buyers (50%), high net-worth individuals (15%), and retail investors (35%).
Blue Jet Healthcare operates three manufacturing facilities in Maharashtra, India. The company serves clients including GE Healthcare AS and Colgate-Palmolive (NYSE:CL) (India) across 39 countries. Despite a drop in FY23 EBITDA to Rs 160 crore on a revenue of Rs 721 crore, Blue Jet Healthcare saw a net profit surge in Q1 FY24, reporting Rs 44.1 crore.
The shares from the IPO will be credited to successful investors’ demat accounts by November 3, and are expected to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) from November 6.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
